3-Mercaptopyruvate sulfurtransferase in hepatocellular carcinoma: Is it an authentic clinical prognostic predictor?

Teh Ia Huo^*, Jia I. Liao, Shu Yein Ho

^*此作品的通信作者

研究成果: Letter › 同行評審

1 引文斯高帕斯（Scopus）

存取文件

@article{ecd3c77d2763463fb5878d35c4dc96cc,

title = "3-Mercaptopyruvate sulfurtransferase in hepatocellular carcinoma: Is it an authentic clinical prognostic predictor?",

keywords = "3-Mercaptopyruvate sulfurtransferase, HCC, prognosis",

author = "Huo, {Teh Ia} and Liao, {Jia I.} and Ho, {Shu Yein}",

note = "Funding Information: This study was supported by a grant from Taipei Veterans General Hospital (VN111‐07, V111C‐011), Taiwan. ",

year = "2022",

doi = "10.1111/liv.15279",

language = "English",

journal = "Liver International",

issn = "1478-3223",

publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - 3-Mercaptopyruvate sulfurtransferase in hepatocellular carcinoma

T2 - Is it an authentic clinical prognostic predictor?

AU - Huo, Teh Ia

AU - Liao, Jia I.

AU - Ho, Shu Yein

N1 - Funding Information: This study was supported by a grant from Taipei Veterans General Hospital (VN111‐07, V111C‐011), Taiwan.

PY - 2022

Y1 - 2022

KW - 3-Mercaptopyruvate sulfurtransferase

KW - HCC

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=85129256655&partnerID=8YFLogxK

U2 - 10.1111/liv.15279

DO - 10.1111/liv.15279

M3 - Letter

C2 - 35460171

AN - SCOPUS:85129256655

SN - 1478-3223

JO - Liver International

JF - Liver International

ER -